'Scent device' could help detect bladder cancer

July 8, 2013, University of Liverpool

Researchers from the University of Liverpool and University of the West of England, (UWE Bristol), have built a device that can read odours in urine to help diagnose patients with early signs of bladder cancer.

There are currently no reliable to screen patients for bladder cancer in the same way that there are for breast and cervical cancers. Previous research has suggested that a particular in the urine could be detected by dogs trained to recognise the scent, indicating that methods of diagnoses could be based on the smell of certain .

The team have now built a device, called ODOREADER that contains a sensor which responds to chemicals in gas emitted from urine. The device, constructed in the laboratories at UWE Bristol's Institute of Biosensor Technology, analyses this gas and produces a 'profile' of the chemicals in urine that can be read by scientists to diagnose the presence of cancer cells in the bladder.

Professor Chris Probert, from the University of Liverpool's Institute of Translational Medicine, explains: "Each year approximately 10,000 people in the UK are diagnosed with bladder cancer. It is a disease that, if caught early, can be treated effectively, but unfortunately we do not have any early other than diagnosis through at the stage when it starts to become a problem."

The device works by inserting a bottle containing the into the device. About 30 minutes later the ODOREADER is capable of showing the diagnosis on the if the sample derives from a patient with bladder cancer.

Professor Norman Ratcliffe, from the Institute of Biosensor Technology at UWE Bristol, said: "It is thought that dogs can smell cancer, but this is obviously not a practical way for hospitals to diagnose the disease. Taking this principle, however, we have developed a device that can give us a profile of the odour in urine. It reads the gases that chemicals in the urine can give off when the sample is heated."

Professor Probert added: "We looked at 98 samples of urine to develop the device, and tested it on 24 patient samples known to have cancer and 74 samples that have urological symptoms, but no cancer. The device correctly assigned 100% of cancer patients.

"Bladder cancer is said to be the most expensive cancer to treat, due to repeated scopes to inspect the development of the in the bladder. ODOREADER has the potential to dramatically cut these costs by preventing scopes.

"These results are very encouraging for the development of new diagnostic tools for bladder cancer, but we now need to look at larger samples of patients to test the device further before it can be used in hospitals."

Explore further: 700 women with urinary cancers in England missing out on prompt diagnosis every year

More information: The work, also in collaboration with Bristol Urological Institute, is published in the journal PLOS ONE.

Related Stories

700 women with urinary cancers in England missing out on prompt diagnosis every year

June 24, 2013
Around 700 women in England with symptoms of kidney or bladder cancer are missing out on prompt diagnosis and treatment of their condition every year, reveals research in the online only journal BMJ Open.

Key find for early bladder cancer treatment

May 23, 2013
Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.

Bladder cancer recurrence and mortality could decline with better treatment compliance

June 5, 2013
(Medical Xpress)—Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce ...

Multi-tasking imatinib boosts radiotherapy for bladder tumours

March 4, 2013
Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research.

Genetic alterations linked with bladder cancer risk, recurrence, progression, and patient survival

March 25, 2013
A new analysis has found that genetic alterations in a particular cellular pathway are linked with bladder cancer risk, recurrence, disease progression, and patient survival. Published early online in Cancer, a peer- reviewed ...

Recommended for you

Single-cell study in a childhood brain tumor affirms the importance of context

April 20, 2018
In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

Aggressive breast cancer already has resistant tumour cells prior to chemotherapy

April 20, 2018
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center ...

Scientists identify 170 potential lung cancer drug targets using unique cellular library

April 19, 2018
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Discovery adds to evidence that some children are predisposed to develop leukemia

April 19, 2018
St. Jude Children's Research Hospital researchers have made a discovery that expands the list of genes to include when screening individuals for possible increased susceptibility to childhood leukemia. The finding is reported ...

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

April 19, 2018
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.